Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective dose of dezocine combined with dexmedetomidine for analgesia during nerve block
ChiCTR-IPR-17014223Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dezocine and dexmedetomidine in pain, sponsored by Tongji Hospital. Primary endpoints: VAS pain score and OAA/S sedation score. Started Jan 2018; status: recruiting.
02
Drugs
dezocinedexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR-IPR-17014223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014223.